arrow
E

Eckard Hamelmann

university of bielefeld
H指数:73
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

作者更正:芳香-乳酸产生型双歧杆菌的早期定植降低了过敏致敏的风险

2026-10-020
PRE
Influence of newly initiated biologic therapy on the dose of ICS therapy - Data from the German Asthma Net

新生物制剂疗法对吸入性糖皮质激素疗法剂量的影响——德国哮喘网数据

2026-09-230
PRE
Efficacy and safety of tiotropium in partial and uncontrolled preschool asthma (TIPP): a phase III, multicentre, randomised, double-blind, placebo-controlled trial

噻托溴铵在部分控制和未控制学龄前哮喘中的有效性与安全性(TIPP):一项III期、多中心、随机、双盲、安慰剂对照试验

2026-09-010
OAAI
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms

严重COVID-19中IL-1Ra和PGRN的自身抗体与炎症诱导的高磷酸化抗原异构体相关

2026-05-270
OAAI
Impact of COVID-19 vaccination on post-COVID syndrome across clinical definitions and phenotypes: a prospective multicenter cohort study

COVID-19疫苗接种对跨临床定义和表型的后COVID综合征的影响:一项前瞻性多中心队列研究

2026-03-160
OAAI
Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

早期生命阶段由芳香族乳酸产生型双歧杆菌定植可降低过敏致敏的风险。

2026-01-120
PRE
Establishing and validating syndromic surveillance of gastrointestinal infections using routine emergency department data, Germany, 2019–2023

基于德国2019–2023年常规急诊科数据建立并验证胃肠道感染的综合征监测

2025-11-030
OAAI
Severe asthma in children and adolescents. Summary of the S1 guidelines under the auspices of the Society for Pediatric Pulmonology (GPP), AWMF register nr. 026/027

儿童和青少年重度哮喘。在德国儿科肺脏学会(GPP)赞助下制定的S1指南摘要,AWMF注册号026/027。

2025-11-010
OAAI
Future-proof care for children and adolescents now! We can no longer afford to provide young people with poor medical treatment

面向未来的儿童与青少年关怀,即刻行动!我们再也无法负担为年轻人提供劣质医疗治疗的代价。

2025-11-010
PRE
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases

通往缓解之路:2型炎症性疾病中不断发展的治疗理念

2025-02-011
OAAI
Development and maintenance of consensus recommendations on pediatric outpatient antibiotic therapy in Germany: a framework for rational use
2025-01-230
OAAI
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
2024-07-012
OA